Alzamend Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 13, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Cap	4	5	5	53	97	-
Market Cap Growth	88.71%	-5.44%	-90.78%	-45.53%	-	-
Enterprise Value	1.7	0.68	4.82	47.91	83.33	0
Last Close Price	1.16	5.94	63.99	738.81	1377.00	-
PB Ratio	2.06	1.17	-1.89	17.42	7.29	-
P/TBV Ratio	1.34	0.68	-	17.52	6.81	-
Debt / Equity Ratio	-	0	-0.12	0	0	0.17
Net Debt / Equity Ratio	-1.24	-0.99	0.03	-1.69	-1.05	-0.79
Net Debt / EBITDA Ratio	0.39	0.89	0.01	0.35	1.14	0.32
Net Debt / FCF Ratio	0.44	0.57	0.01	0.58	2.09	0.59
Quick Ratio	1.46	6.22	0.12	1.79	12.07	2.14
Current Ratio	1.99	6.58	0.14	2.03	12.37	3.24
Return on Equity (ROE)	-214.73%	-657.17%	-4408.31%	-181.47%	-160.92%	-356.06%
Return on Assets (ROA)	-154.05%	-171.81%	-303.57%	-145.56%	-141.37%	-209.53%
Return on Invested Capital (ROIC)	-1973.91%	-996.34%	-3568.90%	-16273.90%	-4721.13%	-860.89%
Return on Capital Employed (ROCE)	-214.52%	-654.54%	-4403.83%	-181.38%	-160.36%	-349.38%
Buyback Yield / Dilution	-765.27%	-507.76%	-2.68%	-9.45%	-22.64%	-1.96%
Total Shareholder Return	-765.27%	-507.76%	-2.68%	-9.45%	-22.64%	-1.96%

SEC Filings: 10-K · 10-Q